Latest Breaking News On - World health organization international agency - Page 8 : comparemela.com

Inspyr Therapeutics, Inc.: Inspyr Therapeutics Further Strengthens Global Intellectual Property WESTLAKE VILLAGE, CA / ACCESSWIRE / February 18, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics for the treatment of cancer, announces additional expansion of its global intellectual property portfolio of adenosine receptor antagonists in China, Eurasia, and Israel. Management continues to execute on the expansion that further provides flexibility to pursue novel treatments based on the specific targets found in multiple types of cancer in different demographics. The issued Eurasia patent and soon to issue Chinese and Israeli patents strengthen the company s global intellectual property portfolio. Per the announcement in December of 2020, 18 patents have already been issued in its intellectual portfolio in potential future commercial markets including the United States, Europe, th

United statesUnited kingdomKostenloser wertpapierhandelCancer immunology researchCancer researchExchange commissionInspyr therapeutics incAmerican cancer societyInspyr therapeuticsStatement regarding forward looking informationPrivate securities litigation reform actInspyr therapeuticAnnual reportQuarterly reportsCancer metastasis treatImmunology research